Tag Archives: 2018

Oti Mabuse Talks Training And Eating Like A Dancer, Plus Strictly 2018

Dancers have the most incredible bodies. Fact. And with Strictly Come Dancing UK in full swing, we’ve all been eyeballing those gorgeous ladies in the shimmer and heels. Oti Mabuse is back at Strictly for her fourth year running, and this time she’s competing with cricketer, Graeme Swann. She’s been in touch and shared a… Read More »

This week in health – 5 October 2018

The week has flown by at talkhealth, so it’s time for our Friday health news round-up. Allergy news makes the headlines Perhaps the biggest health story of the past week or so has been about the sad death of 15-year-old Natasha Ednan-Laperouse, who suffered a cardiac arrest on a flight to France after buying a… Read More »

17 digital health mergers and acquisitions from Q3 2018

The third quarter of 2018 was a surprisingly good one for mergers and acquisitions. MobiHealthNews tracked 17 deals, from Best Buy’s monster acquisition of GreatCall, to positive exits for Boston area startups Herald Health and Circulation, to WebMD’s snapping up consumer healthcare reviews site Vitals. The majority of the deals seem to represent the kind… Read More »

2018 Nobel Prize in Medicine Awarded to 2 Cancer Immunotherapy Researchers

The Nobel Prize in Physiology or Medicine was awarded on Monday to James P. Allison of the United States and Tasuku Honjo of Japan for their work on unleashing the body’s immune system to attack cancer, a breakthrough that has led to an entirely new class of drugs and brought lasting remissions to many patients… Read More »

Weekly Roundup for SEPTEMBER 21, 2018: Recent Publications in Women’s Mental Health

Data on the most recent randomized controlled trial of brexanolone, a novel treatment for postpartum depression, were released. (We will review those in greater detail next week.)   Guidelines for the treatment of perimenopausal depression were also published. Ruta Nonacs, Md PhD Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Meltzer-Brody… Read More »